Raymond James Reiterates Agios Pharma (AGIO) at Market Perform, Continues to Expect a Very Slow Launch, Stock Will Trade Range-Bound Until There is Meaningful Revenue
Tweet Send to a Friend
Raymond James analyst Danielle Brill reiterated a Market Perform rating on Agios Pharma (NASDAQ: AGIO), following approval of the company's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
